Search Results - "Benford, H L"

Visualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro by Benford, H.L, McGowan, N.W.A, Helfrich, M.H, Nuttall, M.E, Rogers, M.J

“…Bisphosphonates inhibit osteoclast-mediated bone resorption by mechanisms that have only recently become clear. Whereas nitrogen-containing bisphosphonates…”
Get full text

The pharmacology of bisphosphonates and new insights into their mechanisms of action by Russell, R. Graham G., Rogers, Michael J., Frith, Julie C., Luckman, Steven P., Coxon, Fraser P., Benford, Helena L., Croucher, Peter I., Shipman, Claire, Fleisch, Herbert A.

“…Bisphosphonates are chemically stable analogs of inorganic pyrophosphate, which are resistant to breakdown by enzymatic hydrolysis. The biological effects of…”
Get full text

Cellular and molecular mechanisms of action of bisphosphonates by ROGERS, M. J, GORDON, S, BENFORD, H. L, COXON, F. P, LUCKMAN, S. P, MONKKONEN, J, FRITH, J. C

Get full text

Molecular mechanisms of action of bisphosphonates by Rogers, M.J, Frith, J.C, Luckman, S.P, Coxon, F.P, Benford, H.L, M̈onkk̈onen, J, Auriola, S, Chilton, K.M, Russell, R.G.G

Get full text

Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: biochemical evidence for two distinct pharmacological classes of bisphosphonate drugs by Benford, H L, Frith, J C, Auriola, S, Mönkkönen, J, Rogers, M J

“…Recently, advances have been made in understanding the molecular mechanisms by which bisphosphonate drugs inhibit bone resorption. Studies with the…”
Get more information

Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs by Coxon, F P, Benford, H L, Russell, R G, Rogers, M J

“…The exact mechanisms of action of antiresorptive bisphosphonate drugs remain unclear, although they may inhibit bone resorption by mechanisms that can lead to…”
Get more information

Cellular and molecular mechanisms of action of bisphosphonates by Rogers, Michael J., Gordon, S., Benford, H. L., Coxon, F. P., Luckman, S. P., Monkkonen, J., Frith, J. C.

“…BACKGROUND Bisphosphonates currently are the most important class of antiresorptive agents used in the treatment of metabolic bone diseases, including…”
Get full text

UR/PSRO long term care data system by Benford, L H, Floyd, R F, Stansel, E H

Get more information